The indications for admission of adult patients with severe infections in the intensive care unit;Indicaciones de ingreso en el servicio de medicina intensiva de pacientes adultos con infecciones graves

Enfermedades Infecciosas y Microbiologia Clinica

Volumn 16, Issue 9, 1998, Pages 423-430

  Álvarez Lerma, Francisco ^a   Cisneros, José Miguel ^b   Fernández Viladrich, Pedro ^c   León, Cristóbal ^d   Miró, José María ^e   Pachón, Jerónimo ^b   Palomar, Mercedes ^f   Rello, Jordi ^g  

^a HOSPITAL DEL MAR   (Spain)

^b Virgen de Rocío Traumatology Hospital   (Spain)

^c HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^d HOSPITAL UNIVERSITARIO DE VALME   (Spain)

^e HOSPITAL CLÍNIC   (Spain)

^f HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^g HOSPITAL DE SABADELL   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CANCER PATIENT; CRITICAL ILLNESS; DISEASE SEVERITY; ENDOCARDITIS; HOSPITAL ADMISSION; HOSPITAL INFECTION; HUMAN; INFECTION RATE; INTENSIVE CARE UNIT; ORGAN TRANSPLANTATION; RESPIRATORY TRACT INFECTION; SEPSIS; TREATMENT INDICATION;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; ENDOCARDITIS, BACTERIAL; HUMANS; IMMUNOLOGIC DEFICIENCY SYNDROMES; INFECTION; INTENSIVE CARE; INTENSIVE CARE UNITS; MENINGITIS; MULTIPLE ORGAN FAILURE; SHOCK, SEPTIC; SPAIN;

EID: 0032431918     PISSN: 0213005X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (71)

1. Hadorn DC, Baker D, Hodges JS, Hicks N. Rating the quality of evidence for clinical practice guidelines. J Clin Epidemiol 1996; 49: 749-754.
2. Testa MA, Simonson DC. Assessment of quality of life outcomes. N Engl J Med 1996; 334: 835-840.
3. Badía X, Salamero M, Alonso J, Ollé A. La medida de la salud. Guía de escalas de medición en español. Barcelona: Promociones y Publicaciones Universitarias, S.A. (PPU, S.A.), 1996.
4. Karnofsky DA, Abelmann WH, Craver LF, Burchenal JH. The use of the nitrogen mustards in the palliative treatment of carcinoma. Cancer 1948; 1: 634-656.
5. Pachón J, Prados MD, Capote F, Cuello JA, Garnacho J, Verano A, Severe community-acquired pneumonia: etiology, prognosis and treatment. Am Rev Respir Dis 1991; 142: 369-373.
6. Torres A, Serra-Batlles J, Ferrer A, Jiménez P, Celis R, Cobo E et al. Severe comunity-acquired pneumonia: epidemiology and prognostic factors. Am Rev Respir Dis 1991; 144: 312-318.
7. Rello J, Quintana E, Ausina V, Net A, Prats G. A three-year study of severe community-acquired pneumonia with emphasis on outcome. Chest 1993; 103: 232-235.
8. Fine MJ, Smith MA, Carson CA, Mutha SS, Sankey SS, Weissfeld LA et al. Prognosis and outcomes of patients with community-acquired pneumonia. A metanalisis. JAMA 1996; 275: 134-141.
9. Rello J, Rodríguez R, Jubert P, Álvarez B and the Spanish Study Group for Severe Community-Acquired Pneumonia. Severe community-acquired pneumonia in the elderly: epidemiology and prognosis. Clin Infect Dis 1996; 23: 723-728.
10. Rello J, Rue M, Jubert P, Muses G, Soñora R, Valles J et al. Survival in patients with nosocomial pneumonia: impact of the severity of illness and the etiologic agent. Crit Care Med 1997; 25: 1.062-1.067.
11. Franklin C, Henrickson K, Weil MH. Reduced mortality of pneumococcal bacteremia after early intensive care. J Intensive Care 1994; 6: 302-307.
12. Niederman MS, Bass JB, Campbell GD, Grossman RF, Mandell LA, Marrie TJ et al. Guidelines for the initial management of adults with community-acquired pneumonia: diagnosis, assessment of severity, and initial antimicrobial therapy. Am Rev Respir Dis 1993; 148: 1.418-1.426.
13. Niederman MS, Campbell GD, Broughton WA, Craven DE, Fein M, Fink M et al. Hospital-acquired pneumonia in adults: diagnosis, assessment of severity, initiai antimicrobial therapy and preventive strategies. Am J Resp Crit Care Med 1996; 153: 1.711-1.725.
14. Tunkel AR, Scheld WM. Acute bacterial meningitis in adults. En: Remington JE, Swartz MN, editores. Current Topics in Infectious Diseases. Boston: Blackwell Science Inc., 1996; 215-239.
15. Batzdorf U. The management of cerebral edema in pediatric practice. Pediatrics 1976; 58: 78-87.
16. Dacey RC. Monitoring and treating intracranial pressure. Pediatric Infect Dis J 1987; 6: 1.161-1.163.
17. Lyons MK, Meyer FB. Cerebrospinal fluid physiology and the managemente of increased intracranial pressure. Mayo Clin Proc 1990; 65: 684-707.
18. Ashwal S, Tomasi L, Schneider S, Perkin R, Thompson J. Bacterial meningitis in children: pathophysiology and treatment. Neurology 1992; 42: 739-748.
19. Pfister HW, Freiden W, Einhäupl KM. Spectrum of complications during bacterial meningitis in adults. Results of a prospective clinical study. Arch Neurol 1993; 50: 575-581.
20. Lacroix J, Deal C, Gauthier M, Rousseau E, Farrell CA. Admissions to a pediatric intensive care unit for status epilepticus: a 10-year experience. Crit Care Med 1994: 22: 827-832.
21. Madagame ET, Havens PL, Bresnahan JM, Babel KJ, Splaingard ML. Survival and functional outcome of children requiring mechanical ventilation during therapy for acute bacterial meningitis. Crit Care Med 1995; 23: 1.279-1.283.
22. Kaplan SL, Feigin RD. Clinical presentations, prognostic factors and diagnosis of bacterial meningitis. En: Sande MA, Smith AL, Root RK, editores. Bacterial meningitis. Nueva York: Churchill Livingstone Inc., 1985; 83-94.
23. Bone RC, Fisher CJ, Clemmer TP, Slotman GJ, Metz CA, Balk RA. Sepsis syndrome: a valid clinical entity. Crit Care Med 1989; 17: 389-393.
24. Members of the European Society of Intensive Care Medicine. The problems of sepsis. An expert report of the European Society of Intensive Care Medicine. Intensive Care Med 1994; 20: 300-304.
25. Members of the American College of Chest Physicians/Society of Critical Care Medicine. Committee Consensus Conference: Definitions for sepsis and failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992; 20: 864-874 y Chest 1992; 101: 1.644-1.655.
26. Members of the American College of Chest Physicians/Society of Critical Care Medicine. Committee Consensus Conference: Definitions for sepsis and failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992; 20: 864-874 y Chest 1992; 101: 1.644-1.655.
27. a ed.). Barcelona: Ediciones Doyma, 1995; 605-614.
28. Steckelberg JM, Murphy JG, Wilson WR. Management of complications of infective endocarditis. En: Kaye D, editor. Infective endocarditis. Nueva York: Raven Press, 1992; 435-453.
29. Murphy JG, Foster-Smith K. Management of complications of infective endocarditis with emphasis on echocardiografic findings. Infect Dis Clin North Am 1993; 7: 153-165.
30. Durack DT, Lukes AS, Bright DK, and the Duke Endocarditis Service. New criteria for diagnosis of infective endocarditis: utilization of specific echocardiographic findings. Am J Med 1994; 96: 200-209.
31. Weinstein L, Brusch JL. Medical management. En: Weinstein L, Brusch JL, editores. Infective endocarditis: Nueva York: Oxford University Press, 1996; 256-304.
32. Wilson WR, Karchmer AW, Dajani AS, Taubert KA, Bayer A, Kaye D et al. Antibiotic treatment of adults with infective endocarditis due to streptococci, enterococci, staphylococci and HACEK microorganisms, American Heart Association. JAMA 1995; 274: 1.706-1.713.
33. Grupo de Trabajo para el Estudio de las Infecciones en Drogadictos, Estudio multicéntrico de las complicaciones infecciosas en adictos a drogas por vía parenteral en Espana: análisis final de 17.592 casos (1977-1991). Enferm Infecc Microbiol Clin 1995; 13: 532-539,
34. Miré JM Wilson WR, Infective endocarditis and other vascular infections in intravenous drug abusers. En: Korzeniowski OM, Mandel GL, editores. Cardiovascular Infections. Vol. X. Atlas of Infectious Diseases. Filadelfia: Churchill Livingstone, 1998; 1: 3-18.
35. Hecht S, Berger M. Right-sided endocarditis in intravenous drug users. Ann Intern Med 1992; 117: 560-566.
36. Torres-Tortosa M, González M, Pérez E, Vergara A, Pérez J, Pérez S et al. Endocarditis infecciosa en heroinomanos eu la provincia de Cádiz. Un estudio multicéntrico sobre 150 episodios. Med Clin (Barc) 1992; 98: 521-526.
37. Witchitz S, Reidiboym M, Bouvet E, Wolff M, Vachon F. Evolution des facteurs pronostiques de l'endocardite infectieuse sur une période de 16 ans. Arch Mal Coeur 1992; 85: 959-965.
38. Goldman ME, Fisher EA, Winters S, Reichstein R, Stavile K, Gorlin R et al. Early identification of patients with native valve infectious endocarditis at risk for major complications by initial presentation and baseline echocardiography. Int J Cardiol 1995; 52: 257-264.
39. Tornos MP, Olona M, Permanyer-Miralda G, Almirante B, Evangelista A, Soler-Soler J. Is the clinical spectrum and prognosis of native valve infective endocarditis in non-addicts changing? Eur Heart J 1995; 16: 1.686-1.691.
40. Erbel R, Liu F, Ge J, Rohmann S, Kupferwasser I. Identification of high-risk subgroups in infective endocarditis and the role of echocardiography. Eur Heart J 1995; 16: 588-602.
41. Ribera E, Miró JM, Cortés E, Cruceta A, Mercé J, Marco F et al. Influence of HIV-1 infection and degree of immunosupression in the clinical characteristics and outcome of infective endocarditis in intravenous drug users, Arch Intern Med 1998; 158: 2.043-2.050.
42. Calderwood SB, Swinski LA, Karchmer AW, Waternaux CM, Buckley MJ. Prosthetic valve endocarditis. Analysis of factors affecting outcome of therapy. J Thorac Cardiovasc Surg 1986; 92: 776-783.
43. Wolf M, Witchitz S, Chastang C, Régnier B and Vachon F. Prognostic factors of overall survival in a series of 122 cases and consequences for treatment decision. Chest 1995; 108: 688-694.
44. Tornos P, Almirante B, Olona M, Permanyer G, González T, Carballo J et al. Clinical outcome and log-term prognosis of late prosthetic valve endocarditis: a 20-year experience. Clin Infect Dis 1997; 24: 381-386.
45. Killip T, Kimball JT. Treatment of myocardial infarction in a coronary care unit. A two year experience with 250 patients. Am J Cardiol 1967; 20: 457-464.
46. Califf RM, Bengtson JR. Cardiogenic shock. N Engl J Med 1994; 330: 1.724-1.730.
47. Alsip SG, Blackstone EH, Kirklin J, Cobbs CG. Indications for cardiac surgery in patients with active infective endocarditis. Am J Med 1985; 78 (Supl 6B): 138-148.
48. Weinstein L, Brusch JL. Surgical management. En: Weinstein L, Brusch JL, editores. Infective endocarditis. Nueva York: Oxford University Press, 1996; 305-321.
49. Mügge A, Daniel WG, Frank C, Lichtlen PR. Echocardiography in infective endocarditis: reassessment of prognostic implications of vegatations size determined by the transthoracic and the tranesophageal approach. J Am Coll Cardiol 1989; 14: 631-638.
50. Daniel W, Mügge A, Martin R, Lindert O, Hausmann D, Nonnast D et al. Improvement in the diagnosis of abscesses associated with endocarditis by transesophageal echocardiography. N Engl J Med 1991; 324: 795-803.
51. Ho M, Dummer JS. Infections in transplant recipients. En: Mandell GL, Bennet JE, Dolin R, editores. Principles and Practice of Infectious Diseases. Nueva York: John Wiley & Sons, 1995; 2.709-2.717.
52. Pizzo PA. Management of fever in patients with cancer and treatment-induced neutropenia. N Engl J Med 1993; 328; 1.323-1.332.
53. Kramer MR, Denning DW, Marshall SE, Ross DJ, Berry G, Lewinston NJ et al. Ulcerative tracheobronchitis after lung trasplantation. A new form of invasive aspergillosis. Am Rev Respir Dis 1991; 144: 552-556.
54. Parrillo JE. Pathogenetic machanisms of septic shock. N Engl J Med 1993; 328: 1.471-1.477.
55. Li TCM, Philips MC, Shaw L, Cook EF, Natanson C, Goldman L. On-site physician staffing in a community hospital intensive care unit: impact on test and procedure use and on patient outcome. JAMA 1984; 252: 2.023-2.027.
56. Crawford SW, Petersen FB. Long-term survival from respiratory failure after marrow transplantation. Am Rev Respir Dis 1992; 145: 510-514.
57. Hogg ES, Heath KV, Yip B, Craib JP, O'Shaughnessy MV, Schechter MT et al. Improved survival among HIV-infected individual folloving initiation of antiretroviral therapy. JAMA 1998; 279: 450-454.
58. Carpenter CC, Fisch MA, Hammer SM, Hirsch MS, Jacobsen DM, Katzenstein DA et al, Antiretroviral therapy for HIV infection in 1997: updated recommendations of the international Aids Society USA Panel. JAMA 1997; 227: 1.962-1.969.
59. a ed.). Madrid: Ministerio de Sanidad y Consumo, 1997; 10: 1-16.
60. Moreno S, Arrizabalaga J, Gatell JM, Clotet B, Aguirrebengoa K, Antela A et al. Recomendaciones sobre el tratamiento antirretroviral. Med Clin (Barc) 1998; 110; 109-116.
61. Sepkowitz KA. Effect of Haart on natural history of AIDS-related opportunistic disorders. Lancet 1998; 351: 228-230.
62. Carr A, Marriott D, Field A, Vasak E, Cooper DA. Treatment of HTV-1-associated mlcrosporidiosis and cryptosporidiosis with combination antirretroviral therapy. Lancet 1998; 351: 256-261.
63. Autran B, Carcelain G, Li TS, Blanc C, Mathez D, Tubiana R et al. Positive effects of combined antiretroviral therapy on CD4+T cell homeostasis and function in advanced HIV disease. Science 1997; 277: 33.
64. Bonastre J, Cebrián J, Gudín J, y Grupo de Trabajo de Enfermedades Infecciosas de la SEMIUC. Características clínicas y supervivencia de los pacientes VIH positivos ingresados en UCI. Med Intensiva 1996; 20: 185-191.
65. Sánchez MA, León C, Lucena F. Infección por VIH y UCI. Problemática y consideraciones. Situación actual. En: C. León G, editor. Infección por VIH y UCI. Madrid: Emisa, 1997; 215-227.
66. Brown MC, Crude WB, Predictive ability of Acute Physiology and Chronic Health Evaluation II Scoring applied to human immunodeficiency virus-positive patients. Crit Care Med 1995; 23: 248-52.
67. Montaner JS, Hawley PH, Ronco JJ, Russell JA, Quieffin J, Lawson LM. Multisystem Organ Failure Predicts Mortality of ICU Patients With Acute Respiratory Failure Secondary to AIDS-Related PCP. Chest 1992; 102: 1.823-1.828.
68. Watcher RM, Luce JM, Sufrin S, Berrios D, Charlebois E, Scitovky AA Cost and outcome of intensive care for patients with AIDS, Pneumocystis carinii pneumonia and severe respiratory failure. JAMA 1995; 273: 230-235.
69. Rosen MJ, Clayton K, Schneider RF, Fulkerson W, Rao AV, Stansell J et al Intensive care of patients with HIV infection: utilization, critical illnesses, and outcomes Pulmonary Complications of HIV Study Group. Am J Respir Crit Care Med 1997; 155: 67-71.
70. Rello J, Villagra A, Cervantes M. Infección por Pneumocystis carinii en pacientes con sida. Pronóstico actual de la insuficiencia respiratoria. Enferm Infecc Microbiol Clin 1995; 13: 447-49.
71. Franklin C, Friedman Y, Wong T, Hu T. Improving long-term prognosis for survivors of mechanical ventilation in patients with AIDS, with PCP and acute respiratory failure. Arch Intern Med 1995; 55: 91-95.